NBCC AIIMS ink MoU to develop phase II of trauma centre
The All India Institute of Medical Sciences, AIIMS has inked an MoU with the National Buildings Constructions Corporation Ltd (NBCC) to build the second phase of the existing trauma centre of the institution.
The construction of the centre, known as Jai Prakash Narayan Apex Trauma centre, has been budgeted at Rs.3,000 crore.
Approximately 15 acres of land will be taken for the upcoming trauma centre that will have 2,250 beds and extended treatment facilities for digestive diseases, head and neck surgery, spine treatment, organ transplant, etc.
"NBCC would also participate in the massive restructuring of AIIMS infrastructure, including the redevelopment of AIIMS residential complexes in its Western Campus and Ayurvigyan Nagar," said Anoop Mittal, CMD, NBCC, in a statement issued by the organisation.
Besides a control room for effective coordination and communication, the facility will have networking linkages with other hospitals and agencies.
A helipad will be built on its roof top so that critically injured patients can be airlifted for immediate medical attention.
Read also....
The construction of the centre, known as Jai Prakash Narayan Apex Trauma centre, has been budgeted at Rs.3,000 crore.
Approximately 15 acres of land will be taken for the upcoming trauma centre that will have 2,250 beds and extended treatment facilities for digestive diseases, head and neck surgery, spine treatment, organ transplant, etc.
"NBCC would also participate in the massive restructuring of AIIMS infrastructure, including the redevelopment of AIIMS residential complexes in its Western Campus and Ayurvigyan Nagar," said Anoop Mittal, CMD, NBCC, in a statement issued by the organisation.
Besides a control room for effective coordination and communication, the facility will have networking linkages with other hospitals and agencies.
A helipad will be built on its roof top so that critically injured patients can be airlifted for immediate medical attention.
Read also....
AIIMS heliport to come up after regulatory clearances
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.